Assure Holdings Corp. (IONM)
NASDAQ: IONM · IEX Real-Time Price · USD
0.889
+0.159 (21.78%)
At close: Apr 25, 2024, 4:00 PM
0.895
+0.006 (0.64%)
After-hours: Apr 25, 2024, 7:54 PM EDT

Company Description

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States.

It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures.

The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures.

Assure Holdings Corp. is based in Englewood, Colorado.

Assure Holdings Corp.
Assure Holdings logo
Country United States
Founded 2016
Industry Medical Care Facilities
Sector Healthcare
Employees 127
CEO John Allen Farlinger C.A.

Contact Details

Address:
7887 East Belleview Avenue, Suite 500
Greenwood Village, Colorado 80111
United States
Phone 720-287-3093
Website assureneuromonitoring.com

Stock Details

Ticker Symbol IONM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001798270
CUSIP Number 04625J204
ISIN Number US04625J3032
Employer ID 82-2726719
SIC Code 3841

Key Executives

Name Position
John Allen Farlinger C.A. Executive Chairman and Chief Executive Officer
Paul Webster Interim Chief Financial Officer and Senior Vice President of Managed Care & Revenue Cycle Management
Jerod Powell Chief Information Officer
Sherri Wagner Vice President of Human Resources

Latest SEC Filings

Date Type Title
Apr 24, 2024 425 Filing
Apr 24, 2024 8-K Current Report
Apr 24, 2024 DEFR14A Filing
Apr 16, 2024 DEF 14A Other definitive proxy statements
Apr 12, 2024 425 Filing
Apr 12, 2024 8-K Current Report
Apr 2, 2024 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Apr 1, 2024 425 Filing
Apr 1, 2024 8-K Current Report
Mar 29, 2024 PRE 14A Other preliminary proxy statements